Abstract:Our findings indicate that obliteration of the fistulous tract with BioGlue adversely affects the outcome of TAFR for high transsphincteric fistulas.
“…This phenomenon has not been specifically described in previous studies on AGG, although inflammation and toxic effects were seen [20][21][22], which may trigger this type of pathological tissue integration. Our findings with AGG are analogous to previously published results of cyanoacrylate mesh fixation in the onlay model, where inhibition of tissue integration triggered by the adhesive was seen [12].…”
Section: Discussionmentioning
confidence: 75%
“…Clinical application of the adhesive in pancreas resection did not reduce incidence of [27]. A study on the use of AGG for the treatment of anal fistula was terminated prematurely because of complications such as discharge of great amounts of purulent liquid and abscess formation [21]. Wound complications were seen after use of AGG in a neurosurgical study [28].…”
The fibrin sealant adhesive showed very good overall results of the primary and secondary outcome parameters. FS is a recommendable atraumatic fixation tool for the surgical onlay technique. AGG provides high adhesive strength, but shows low biocompatibility. Persisting active inflammation was seen in both the O-AGG and I-AGG groups, not favoring its use for these indications.
“…This phenomenon has not been specifically described in previous studies on AGG, although inflammation and toxic effects were seen [20][21][22], which may trigger this type of pathological tissue integration. Our findings with AGG are analogous to previously published results of cyanoacrylate mesh fixation in the onlay model, where inhibition of tissue integration triggered by the adhesive was seen [12].…”
Section: Discussionmentioning
confidence: 75%
“…Clinical application of the adhesive in pancreas resection did not reduce incidence of [27]. A study on the use of AGG for the treatment of anal fistula was terminated prematurely because of complications such as discharge of great amounts of purulent liquid and abscess formation [21]. Wound complications were seen after use of AGG in a neurosurgical study [28].…”
The fibrin sealant adhesive showed very good overall results of the primary and secondary outcome parameters. FS is a recommendable atraumatic fixation tool for the surgical onlay technique. AGG provides high adhesive strength, but shows low biocompatibility. Persisting active inflammation was seen in both the O-AGG and I-AGG groups, not favoring its use for these indications.
“…Halverson et al [18] reported an overall healing rate of only 30% in patients who underwent transanal advancement flap repair for persistent rectovaginal fistula. It seems unlikely that the rather poor outcome of flap repair for rectovaginal fistula can be improved by application of glue, since it has been shown recently that obliteration of trans-sphincteric fistulous tracts with Bioglue Ò adversely affects the outcome of flap repair [20]. Based on these data it seems obvious that persistent rectovaginal fistulas are difficult to treat by a transanal advancement repair.…”
Based on these early results, rectal sleeve advancement, either by a posterior "Kraske" approach, or by an abdominal approach, seems to be a valuable alternative for the treatment of persistent rectovaginal fistulas.
“…It remains intact for up to 2 years and is then resorbed slowly and replaced by normal tissue without causing a chronic inflammatory state. 7 There has been a lot of interest in less invasive procedure with the introduction of bioprosthetic fistula plug made from porcine intestinal submucosa (Anal Fistula Plug, Cook Surgical, Inc., Bloomington, IN). Although original designed for anal fistulas, has moved into being used for RVFs with success and continues to be evaluated and has been studied in randomized clinical trials comparing surgical versus fistula plug with mixed results.…”
Although the use of Bioglue(®) may not be suitable for all patients with rectovaginal fistulas, it offers yet another treatment modality for select patients.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.